Anti-HHV-8 HELI Polyclonal Antibody: A Powerful Tool for Studying HHV-8 Infection
The Anti-HHV-8 HELI Polyclonal Antibody is a highly specific and sensitive antibody designed for the detection and study of Human Herpesvirus 8 (HHV-8) infection. This antibody is a valuable research tool for scientists and researchers studying the pathogenesis and treatment of HHV-8-associated diseases.
Biological Function:
HHV-8, also known as Kaposi’s sarcoma-associated herpesvirus (KSHV), is a member of the Herpesviridae family and is the causative agent of Kaposi’s sarcoma, a type of cancer commonly found in immunocompromised individuals. HHV-8 is also associated with other diseases such as primary effusion lymphoma and multicentric Castleman’s disease.
The Anti-HHV-8 HELI Polyclonal Antibody specifically targets the HELI (HHV-8 early lytic antigen) protein, which is expressed during the early stages of HHV-8 infection. This antibody is able to recognize and bind to the HELI protein, allowing for the detection and characterization of HHV-8 infection.
Main Applications:
The Anti-HHV-8 HELI Polyclonal Antibody is a valuable tool for a wide range of applications, including:
1. Detection of HHV-8 infection: This antibody can be used in various techniques such as immunohistochemistry, immunofluorescence, and Western blotting to detect the presence of HHV-8 in tissue samples or cell cultures.
2. Study of HHV-8 pathogenesis: The Anti-HHV-8 HELI Polyclonal Antibody can be used to study the mechanisms of HHV-8 infection and its role in the development of HHV-8-associated diseases.
3. Screening for potential anti-HHV-8 drugs: This antibody can be used in drug screening assays to identify potential compounds that can inhibit HHV-8 infection.
Experimental Use Cases:
The Anti-HHV-8 HELI Polyclonal Antibody has been used in various studies to investigate the role of HHV-8 in different diseases. Some examples include:
1. A study published in the Journal of Virology used this antibody to identify the role of HHV-8 in the development of Kaposi’s sarcoma in HIV-infected individuals.
2. In another study published in PLOS Pathogens, the Anti-HHV-8 HELI Polyclonal Antibody was used to investigate the role of HHV-8 in the development of primary effusion lymphoma.
3. This antibody has also been used in drug screening assays to identify compounds that can inhibit HHV-8 infection, as reported in a study published in Antimicrobial Agents and Chemotherapy.
In conclusion, the Anti-HHV-8 HELI Polyclonal Antibody is a powerful tool for studying HHV-8 infection and its associated diseases. With its high specificity and sensitivity, this antibody is an essential component in any research related to HHV-8. Order now and take your research on HHV-8 to the next level!
There are no reviews yet.